Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brausi

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|April 1, 1988
[Local peptichemio prophylaxis in surface tumors of the bladder (Ta-T1 stage)]L Croce, P D Palladini, M Brausi, et al.
Pathology, Research and Practice|April 1, 1994
Expression of p53 protein in prostate cancers of different histologic typesL Losi, C Di Gregorio, M Brausi, et al.
Urology|November 1, 1987
Comparison of single agent cisplatin and cisplatin containing combinations in treatment of murine bladder cancerD P Hickey, M Brausi, A F Blatnik, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|July 1, 1990
[Primary transitional-cell carcinoma of the male anterior urethra]G Verrini, F Ferrari, M Brausi, et al.
Prostate Cancer and Prostatic Diseases|December 10, 2003
A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasiaP Rigatti, M Brausi, R M Scarpa, et al.
The Journal of Urology|February 15, 2001
The ablative effect of quarter dose bacillus Calmette-Guerin on a papillary marker lesion of the bladderD Mack, W Höltl, P Bassi, et al.
European Urology|June 1, 2000
Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary GroupK H Kurth, C Bouffioux, R Sylvester, et al.
European Urology|December 26, 2001
Frequency of positive biopsies after visual disappearance of superficial bladder cancer marker lesionsW Oosterlinck, A V Bono, D Mack, et al.
European Urology|July 27, 1999
Significance of bladder biopsies in Ta,T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder CommitteeA van der Meijden, W Oosterlinck, M Brausi, et al.
The Journal of Urology|July 18, 2001
Intravesical instillation of epirubicin, bacillus Calmette-Guerin and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder: a European Organization for Research and Treatment of Cancer genito-urinary group randomized phase III trialA P van der Meijden, M Brausi, V Zambon, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|April 1, 1988
[Local peptichemio prophylaxis in surface tumors of the bladder (Ta-T1 stage)]L Croce, P D Palladini, M Brausi, et al.
Pathology, Research and Practice|April 1, 1994
Expression of p53 protein in prostate cancers of different histologic typesL Losi, C Di Gregorio, M Brausi, et al.
Urology|November 1, 1987
Comparison of single agent cisplatin and cisplatin containing combinations in treatment of murine bladder cancerD P Hickey, M Brausi, A F Blatnik, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|July 1, 1990
[Primary transitional-cell carcinoma of the male anterior urethra]G Verrini, F Ferrari, M Brausi, et al.
Prostate Cancer and Prostatic Diseases|December 10, 2003
A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasiaP Rigatti, M Brausi, R M Scarpa, et al.
The Journal of Urology|February 15, 2001
The ablative effect of quarter dose bacillus Calmette-Guerin on a papillary marker lesion of the bladderD Mack, W Höltl, P Bassi, et al.
European Urology|June 1, 2000
Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary GroupK H Kurth, C Bouffioux, R Sylvester, et al.
European Urology|December 26, 2001
Frequency of positive biopsies after visual disappearance of superficial bladder cancer marker lesionsW Oosterlinck, A V Bono, D Mack, et al.
European Urology|July 27, 1999
Significance of bladder biopsies in Ta,T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder CommitteeA van der Meijden, W Oosterlinck, M Brausi, et al.
The Journal of Urology|July 18, 2001
Intravesical instillation of epirubicin, bacillus Calmette-Guerin and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder: a European Organization for Research and Treatment of Cancer genito-urinary group randomized phase III trialA P van der Meijden, M Brausi, V Zambon, et al.
Pageof 4